In accordance with the Food and Drug Safety Administration's change order for drug manufacturing (import) product approval (Drug Management Division-No. 9511, effective date 2008.08.26), the precautions for use of Glymine Tablets and the dosage of Palmclova Tablets have been changed.
For further details, please refer to the ‘Product Introduction’ section and attached documents.
Glimin Tab.
Attachments are original documents and may be in Korean. English editions are labeled separately.
gliminjeong.hwp9. Change order for permission (Glee Minjeong) (2008.08.26).hwp · 23 KBDownload ↓